Posted on 7/7/20

Ties With Merck Could Explain Kitov's Market Interest

SummaryKitov Pharma is a clinical-stage business developing treatments for tumor immune evasion as well as drug resistance.KTOV’s shareholders most likely already know that the company acquired . . .